We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase II Study of Degarelix in the Management of Non-Metastatic Hormone-Refractory Prostate Cancer (OTT 10-06)

This study has been terminated.
(Negative study; Principal Investigator chose to prematurely terminate the study.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01545882
First Posted: March 7, 2012
Last Update Posted: July 23, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Ottawa Hospital Research Institute
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2013
  Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)